3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-5,6,7,8,-tetrahydro-1,2,4-triazolo(4,3-a)pyridine hydrochloride,
dapiprazole,
dapiprazole hydrochloride,
Remydrial,
Rev-Eyes,
Dapiprazole hydrochloride,
72822-13-0,
Dapiprazole HCl,
Rev-Eyes,
Dapiprazole (hydrochloride),
Glamidolo,
UNII-DS9UJN1I0X,
Reversil,
DS9UJN1I0X,
DAPIPRAZOLEHYDROCHLORIDE,
Dapiprazole hydrochloride [USAN],
Remydrial,
AF 2139,
AF-2139,
DSSTox_CID_28595,
DSSTox_RID_82866,
DSSTox_GSID_48669,
Dapiprazole hydrochloride (USAN),
3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine hydrochloride,
CAS-72822-13-0,
Rev-Eyes (TN),
Reversil Hydrochloride,
Glamidolo Hydrochloride,
AC1OCENK,
dapiprazole-hydrochloride,
SCHEMBL667604,
CHEMBL1201044,
DTXSID7048669,
HY-A0142A,
AOB6054,
Tox21_113035,
AKOS015966533,
Tox21_113035_1,
AC-8851,
AN-7595,
API0002214,
CS-5720,
NCGC00262927-01,
AS-16932,
BC677609,
Dapiprazole hydrochloride, >=98% (HPLC),
AK00433062,
FT-0665471,
D03648,
822D130,
A837632,
C-23865,
3-(2-(4-o-tolylpiperazin-1-yl)ethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine hydrochloride,
3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine hydrochloride,
3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine,hydrochloride,
3-[2-[4-(o-tolyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine hydrochloride,
5,6,7,8-Tetrahydro-3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-1,2,4-Triazolo[4,3-a]pyridine Hydrochloride,
Dapiprazole,
Dapiprazole monohydrochloride,
C19H27N5.ClH,
C19H27N5.HCl,
C19-H27-N5.Cl-H,
FMOC-D-3-IODOPHENYLALANINE,
CID6917787,
NCGC00188443-01,
X0004,
72822-12-9,
5,6,7,8-Tetrahydro-3-(2-(4-o-tolyl-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine monohydrochloride,
1,2,4-Triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-, monohydrochloride,